|
PEV3A is a prophylactic malaria vaccine that acts against various stages of the disease. It is a two-component vaccine that contains the virosome formulated peptide mimetics
PEV301 and PEV302. The two synthetic peptide vaccine
components mimic the native structure of important antigens of the malaria parasite. The elicited
antibodies are highly specific and able to inhibit the parasite’s ability to invade liver tissue in
vitro.
|
